Cell Death and Disease · 2022 · 13 citations · 42 references
Life SciencesMolecular BiologyOncologyEpigeneticsEpigenomicsMolecular OncologyCancer EpigeneticsCancer EpigenomicsChromatinEpigenetic AlterationsEpigenetic Alterations In CancerEpigenetic Regulation In CancerEpigenetic ControlEpigenetic Target ValidationGlycogen Synthase Kinase 3 RegulationGlycolytic PathwaysLysosomal Biogenesis In AutophagyPost-translational Histone ModificationsSomatic Genomic AlterationsT-cell Acute Lymphoblastic Leukemia
Genomic studies have identified recurrent somatic alterations in genes involved in DNA methylation and post-translational histone modifications in acute lymphoblastic leukemia (ALL), suggesting new opportunities for therapeutic interventions. In this study, we identified G9a/EHMT2 as a potential target in T-ALL through the intersection of epigenome-centered shRNA and chemical screens. We subsequently validated G9a with low-throughput CRISPR-Cas9-based studies targeting the catalytic G9a SET-domain and the testing of G9a chemical inhibitors in vitro, 3D, and in vivo T-ALL models. Mechanistically we determined that G9a repression promotes lysosomal biogenesis and autophagic degradation associated with the suppression of sestrin2 (SESN2) and inhibition of glycogen synthase kinase-3 (GSK-3), suggesting that in T-ALL glycolytic dependent pathways are at least in part under epigenetic control. Thus, targeting G9a represents a strategy to exhaust the metabolic requirement of T-ALL cells.
42
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina, Giordano Caponigro, Nicolas Stransky et al. · Nature · 2012 · 8.5K citations
Medicine, Oncology, Pharmacology +15
Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing
Ru Cao, Liangjun Wang, Hengbin Wang et al. · Science · 2002 · 3.8K citations